•  
  •  
  •  
  •  

2025-11-02 22:26:06

  • Home
  • Commodities
  • Industry News
  • IPO
  • Mutual Funds
  • Others
  • Research
  • Watch List
Latest News
  • Mahindra Farm Equipment Business Sells 72,071 Tractors in India during October 2025, registering a growth of 12%
  • Meet the Mahindra XEV 9S: The Big New 7-Seater Electric SUV
  • Maruti Suzuki announces sales of 220,894 units in October 2025
  • Mahindra's Trucks & Buses Business sells 2034 vehicles in October, registering a 14% growth
  • VST Tillers Tractors Ltd reports 89.36% growth in October 2025 sales

Keywords Selected:  LifeSciences

IPO News

  • Shilpa Pharma Lifesciences Ltd to file for IPO

Stock Report

  • Eiko Lifesciences Ltd Q2FY26 consolidated PAT increases to Rs. 1.07 crore
  • Sai Life Sciences set to double Process R&D capacity with new facility in Hyderabad
  • Zydus receives approval from Health Canada for Mesalamine suppositories
  • RPG Life Sciences Ltd Q2 FY2026 PAT surges to Rs. 36.85 crores
  • Sai Life Sciences, Agility Life Sciences, and Centrix Pharma announce an 'Integrated CMC Partnership' to accelerate drug development for innovators
  • Zydus receives approval from Health Canada for Liothyronine tablets 5 mcg and 25 mcg
  • Zydus receives final approval from USFDA for Deflazacort oral suspension, 22.75 mg/mL
  • Sentynl Therapeutics updates on its NDA for CUTX-101
  • Zydus and Pinkathon join hands to drive awareness on breast cancer across India
  • Zydus receives EIR for the oncology injectable manufacturing facility in SEZ1, Ahmedabad
  • Sai Life Sciences opens dedicated facility for Veterinary APIs in Bidar, India
  • ZyVet® launches affordable Furosemide tablets to support long-term heart care trusted diuretic for dogs and cats now available in a generic form
  • ZyVet® Launches First Generic Treatment for Canine Urinary Incontinence
  • Closure of USFDA inspection at Zydus' injectable manufacturing plant at Jarod
  • Zydus and Synthon entered into exclusive licensing and supply agreement for Ozanimod Capsules for the U.S. market
  • Zydus launches VaxiFlu™ India's first trivalent influenza vaccine for flu protection
  • Sai Life Sciences completes Phase II of Production Block 11 at Bidar, India, expands capacity to 700 KL
  • Eris Lifesciences receives ANVISA approval for Sterile Injectable Facility
  • Eris Lifesciences Receives ANVISA approval at its Ahmedabad campus
  • Cohance Lifesciences announces ₹230 mn investment and progress on cGMP Oligonucleotide Facility at Hyderabad, India
  • Cohance Lifesciences announces USD 10 mn investment in cGMP Bioconjugation Suite at NJ Bio, Princeton, NJ, U.S. to Accelerate ADC Innovation
  • Nectar Lifesciences Ltd's Unit VI gets CGMP certification from SMDC
  • Zydus receives final approval from USFDA for Diltiazem Hydrochloride Tablets USP, 30 mg, 60 mg, 90 mg, and 120 mg
  • Zydus receives final approval from USFDA for Prucalopride Tablets, 1 mg and 2 mg

Latest Post

  • Mahindra Farm Equipment Business Sells 72,071 Tractors in India during October 2025, registering a growth of 12%
  • Meet the Mahindra XEV 9S: The Big New 7-Seater Electric SUV
  • Maruti Suzuki announces sales of 220,894 units in October 2025
  • Mahindra's Trucks & Buses Business sells 2034 vehicles in October, registering a 14% growth
  • VST Tillers Tractors Ltd reports 89.36% growth in October 2025 sales


Announcement

To Advertise in our website please e-mail us at advertisement@equitybulls.com
Companies can send their Press Releases to pressrelease@equitybulls.com

Links

  • Home
  • Contact
  • Our Team

Contact

The website is developed and maintained by Chennai Scripts
C-4, Podhigai Flats, Pillayar Koil Street, Nesapakkam
Chennai
Tamil Nadu
India
600078
E-mail: chennaiscripts@gmail.com
Mobile Phone Number: +91-88776-69935
www.chennaiscripts.com

Website Created & Maintained by : Chennai Scripts
Nesapakkam, Chennai - 600 078,
Tamil Nadu, India

Disclaimer Copyright © - 2024